Human TFPI/EPI/LACI ORF/cDNA clone-Lentivirus particle (NM_006287)
Cat. No.: vGMLP004933
Pre-made Human TFPI/EPI/LACI Lentiviral expression plasmid for TFPI lentivirus packaging, TFPI lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
TFPI/EPI products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP004933 | Human TFPI Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP004933 |
| Gene Name | TFPI |
| Accession Number | NM_006287 |
| Gene ID | 7035 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 915 bp |
| Gene Alias | EPI,LACI,TFI,TFPI1 |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGATTTACACAATGAAGAAAGTACATGCACTTTGGGCTTCTGTATGCCTGCTGCTTAATCTTGCCCCTGCCCCTCTTAATGCTGATTCTGAGGAAGATGAAGAACACACAATTATCACAGATACGGAGTTGCCACCACTGAAACTTATGCATTCATTTTGTGCATTCAAGGCGGATGATGGCCCATGTAAAGCAATCATGAAAAGATTTTTCTTCAATATTTTCACTCGACAGTGCGAAGAATTTATATATGGGGGATGTGAAGGAAATCAGAATCGATTTGAAAGTCTGGAAGAGTGCAAAAAAATGTGTACAAGAGATAATGCAAACAGGATTATAAAGACAACATTGCAACAAGAAAAGCCAGATTTCTGCTTTTTGGAAGAAGATCCTGGAATATGTCGAGGTTATATTACCAGGTATTTTTATAACAATCAGACAAAACAGTGTGAACGTTTCAAGTATGGTGGATGCCTGGGCAATATGAACAATTTTGAGACACTGGAAGAATGCAAGAACATTTGTGAAGATGGTCCGAATGGTTTCCAGGTGGATAATTATGGAACCCAGCTCAATGCTGTGAATAACTCCCTGACTCCGCAATCAACCAAGGTTCCCAGCCTTTTTGAATTTCACGGTCCCTCATGGTGTCTCACTCCAGCAGACAGAGGATTGTGTCGTGCCAATGAGAACAGATTCTACTACAATTCAGTCATTGGGAAATGCCGCCCATTTAAGTACAGTGGATGTGGGGGAAATGAAAACAATTTTACTTCCAAACAAGAATGTCTGAGGGCATGTAAAAAAGGTTTCATCCAAAGAATATCAAAAGGAGGCCTAATTAAAACCAAAAGAAAAAGAAAGAAGCAGAGAGTGAAAATAGCATATGAAGAAATTTTTGTTAAAAATATGTGA |
| ORF Protein Sequence | MIYTMKKVHALWASVCLLLNLAPAPLNADSEEDEEHTIITDTELPPLKLMHSFCAFKADDGPCKAIMKRFFFNIFTRQCEEFIYGGCEGNQNRFESLEECKKMCTRDNANRIIKTTLQQEKPDFCFLEEDPGICRGYITRYFYNNQTKQCERFKYGGCLGNMNNFETLEECKNICEDGPNGFQVDNYGTQLNAVNNSLTPQSTKVPSLFEFHGPSWCLTPADRGLCRANENRFYYNSVIGKCRPFKYSGCGGNENNFTSKQECLRACKKGFIQRISKGGLIKTKRKRKKQRVKIAYEEIFVKNM |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Biosimilar | GMP-Bios-ab-118 | Pre-Made Concizumab biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI therapeutic antibody |
| Biosimilar | GMP-Bios-ab-053 | Pre-Made Befovacimab biosimilar, Whole mAb, Anti-TFPI Antibody: Anti-EPI/LACI/TFI therapeutic antibody |
| Target Antibody | GM-Tg-g-T78890-Ab | Anti-TFPI1/ TFPI/ EPI monoclonal antibody |
| Target Antigen | GM-Tg-g-T78890-Ag | TFPI VLP (virus-like particle) |
| ORF Viral Vector | pGMLP004933 | Human TFPI Lentivirus plasmid |
| ORF Viral Vector | pGMLV002019 | Human TFPI Lentivirus plasmid |
| ORF Viral Vector | vGMLP004933 | Human TFPI Lentivirus particle |
| ORF Viral Vector | vGMLV002019 | Human TFPI Lentivirus particle |
Target information
| Target ID | GM-T78890 |
| Target Name | TFPI |
|
Gene Group Identifier (Target Gene ID in Homo species) |
7035 |
| Gene ID |
100068873 (Equus caballus), 101098813 (Felis catus), 21788 (Mus musculus), 29436 (Rattus norvegicus) 403921 (Canis lupus familiaris), 508763 (Bos taurus), 613026 (Macaca mulatta), 7035 (Homo sapiens) |
| Gene Symbols & Synonyms | TFPI,Tfpi,EPI,LACI,A630013F22Rik,TFI,TFPI1 |
| Target Alternative Names | A630013F22Rik,EPI,Extrinsic pathway inhibitor (EPI),LACI,Lipoprotein-associated coagulation inhibitor (LACI),TFI,TFPI,TFPI1,Tfpi,Tissue factor pathway inhibitor |
| Uniprot Accession |
O54819,P10646,Q02445,Q28864
Additional SwissProt Accessions: O54819,Q02445,Q28864,P10646 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, INN Index |
| Disease | cancer, Lung Cancer |
| Disease from KEGG | Complement and coagulation cascades |
| Gene Ensembl | ENSECAG00000021849, ENSMUSG00000027082, ENSCAFG00845018905, ENSBTAG00000049919, ENSMMUG00000009448, ENSG00000003436 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


